Pharmalijn SRL
Pharmalijn reported total assets of 797,487 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jul 2026).
The score of Pharmalijn shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +13 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmalijn's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 19 Jul 2024
- Year ended 31 Dec 2022filed on 10 May 2023
- Year ended 31 Dec 2021filed on 06 Jul 2022
Pharmalijn's financial analysis
- Solvency93.8%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmalijn
Pharmalijn's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0860.097.218
- VAT number
- BE0860097218
- Peppol
- Registered · 0208:0860097218 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Aug 2003
- Registered office
- 2970 Schilde
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Pharmalijn (SRL) has been based in Schilde since 2003, active in: activities of holding companies. For 2025, it reports a net profit of 34,519 € and equity of 748,258 €; its revenue is not published. Its solvency stands at 93.8%, above the median of its sector (55.6%).
Companies similar to Pharmalijn
Companies in the same business, of comparable size and area, outside its group.
- Zakenkantoor Depinois-Ghyselen Activities of holding companies Ypres · balance sheet 797,605 €
- Salvus Activities of holding companies Kuurne · balance sheet 798,031 €
- Belika Activities of holding companies Raeren · balance sheet 798,161 €
- Isia Management Activities of holding companies Woluwe-Saint-Pierre · balance sheet 798,277 €
- IIke Mels Activities of holding companies Sint-Gillis-Waas · balance sheet 798,461 €
- Johan Smet Activities of holding companies Sint-Niklaas · balance sheet 796,376 €
- QL Invest Activities of holding companies Staden · balance sheet 798,698 €
- CITCO Belgium Activities of holding companies Etterbeek · balance sheet 796,183 €
Frequently asked questions about Pharmalijn
What is the revenue of Pharmalijn?
Pharmalijn files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmalijn?
In Belgium, the VAT number is the company number prefixed with BE: BE0860097218 for Pharmalijn, if the company is VAT-registered. Its company number (CBE) is 0860.097.218.
Where is the registered office of Pharmalijn?
According to the CBE register, the registered office of Pharmalijn is in 2970 Schilde.
What is the equity of Pharmalijn?
At the close of the 2025 financial year, the equity of Pharmalijn amounts to 748,258 €, a solvency of 93.8% of total assets.
Who manages Pharmalijn?
The register lists 3 active mandates at Pharmalijn. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmalijn
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →